Cell-free DNA analysis for noninvasive examination of trisomy.
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesPlacental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentRecent advances in prenatal genetic screening and testingAccuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysisSpanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections.Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis.The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.Copy-number variation and false positive prenatal aneuploidy screening results.Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessmentsDevelopment and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods studyRepeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)?Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy.Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood.Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.Chloe's Law: A Powerful Legislative Movement Challenging a Core Ethical Norm of Genetic Testing.Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18.Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods StudyPositive Attitudes towards Non-Invasive Prenatal Testing (NIPT) in a Swedish Cohort of 1,003 Pregnant WomenReproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast CancerAnalysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number VariationImproving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma.How can we improve amniocentesis decision-making?PURLs: Aneuploidy screening: Newer noninvasive test gains tractionCirculating Cell Free DNA in the Diagnosis of Trophoblastic TumorsPrenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysisNoninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases.Novel window on early human neurodevelopment via fetal exosomes in maternal blood.Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.Emerging and Disruptive TechnologiesA qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy.Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies.Not-so-free testing for cell-free DNA.IONA test for first-trimester detection of trisomies 21, 18 and 13.Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals.Analysis of cell-free fetal DNA for non-invasive prenatal diagnosis in a family with neonatal diabetes.Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory
P2860
Q26764809-B8D5F162-C114-4134-AF6B-449A4418BA5BQ26766128-2B14CE1A-6CFF-404C-AD3A-A25B818671CDQ28071888-25DC952A-7F9A-4A78-B190-9D162CE784A4Q28072788-74BD68A5-1B60-462B-8954-24F1F5B90C92Q30197052-77978E71-E82F-4795-A325-ED83D9BDB8D2Q30234867-4CFDDE49-1251-4A08-9739-4E3F464FB281Q30250029-6CC07281-B38F-4E39-A667-7F88B07A50A1Q30643919-245BB0A2-9D19-4BE2-9367-B73D93F55927Q30667824-08C3E68C-46DD-4D23-A582-F7B0168985EBQ30847203-3CC76A69-6650-463E-90E3-EB540378D030Q33437396-2FEE479F-F43F-4044-9CC1-5922A636082DQ33634130-823EF494-56CA-4CE6-8A56-A58120D7CD1BQ33699830-22D39083-6DD8-4CCE-8CF1-95859ED66387Q33885707-680B6760-3C1C-4F7C-9B47-CB6CD3E7C012Q34535626-5F12492A-A701-44E6-8233-DD872DA0B93FQ35686965-CC998C0B-89A7-49C7-A615-CD11E87B6FFBQ35738743-5C02B801-6582-4C0C-9CCC-F9F28E4AB38CQ35763064-A0568C4E-A5BD-4B08-8591-829532542BB5Q35979539-492476B2-CEDF-4288-ABCE-5773E7D1C22DQ36022080-8BCBF5E2-4FAB-451A-BBB4-75134347E593Q36168078-5FE0E6B5-25EF-41D5-AC37-E386F254AE45Q36173927-DE53ACCE-ECC3-4478-A3E7-EE255738EDA5Q36245906-B7291F42-FCA0-4237-8D40-A8C6676F9DDDQ36293841-6C60AE40-AD20-4134-88D5-8050A7148A64Q36384651-ABDE0AB3-869C-43BB-8B3C-AF0BF78D4C53Q36550390-8353DAC4-84CB-4643-9DDD-84FB4E60019DQ36586816-C0739A26-56DE-478C-ADCE-B34E982FFABDQ36645051-BE1C77F2-641A-4EBA-AE4A-08A7252EB8BDQ36647328-2F15375B-8B29-436E-B91D-D27B9B628A74Q36762710-1421B134-68E0-4250-8AB8-4FF84E1DAA7CQ36891731-7BFAFD1C-59A1-4018-8E3A-E3A153B90A8EQ37067727-D2940332-BE2F-4A7B-BCD1-65996D0FA63DQ37229325-07C069D6-237B-4C59-9E51-D1DF06AADC78Q37316476-A028382F-1A98-4184-A64F-557BAF5FB5CEQ37325876-80F49410-F747-462A-A190-C62A72F055BFQ37338477-39D304CD-4669-49AB-94D1-99E37D011112Q37340438-E925E89B-A95A-47CB-BA4C-9FA891373EB0Q37351480-4D859B21-4578-4394-ABEF-5250526DC568Q37395481-21C812A3-8E54-4CC5-9C4A-538EB3243885Q37412801-0FD49CBA-342D-44AD-A648-77CE7375012C
P2860
Cell-free DNA analysis for noninvasive examination of trisomy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Cell-free DNA analysis for noninvasive examination of trisomy.
@en
Cell-free DNA analysis for noninvasive examination of trisomy.
@nl
type
label
Cell-free DNA analysis for noninvasive examination of trisomy.
@en
Cell-free DNA analysis for noninvasive examination of trisomy.
@nl
prefLabel
Cell-free DNA analysis for noninvasive examination of trisomy.
@en
Cell-free DNA analysis for noninvasive examination of trisomy.
@nl
P2093
P356
P1476
Cell-free DNA analysis for noninvasive examination of trisomy.
@en
P2093
Angela C Ranzini
Bo Jacobsson
Desiree Hollemon
Geeta K Swamy
Howard Cuckle
Jean L Spitz
Leonardo Pereira
Mark W Tomlinson
Mary E Norton
P304
P356
10.1056/NEJMOA1407349
P407
P577
2015-04-01T00:00:00Z